Saccharolytic SCFAs (Acetate, Butyrate, Proprionate) Test · Stool

When your gut bacteria ferment fiber, they produce three small acids that quietly shape your colon, your metabolism, and your immune system: acetate, propionate, and butyrate. The amount sitting in your stool is one of the most direct readouts of how productive your microbial community actually is.

Most stool tests describe which bacteria you have. This one tells you what those bacteria are doing. If your fiber-fermenting microbes are thriving, these acids show up in expected amounts. If they are starved, displaced, or disrupted by antibiotics or disease, the pattern shifts in ways linked to gut inflammation, colorectal cancer risk, and metabolic health.

What These Acids Actually Do in Your Body

Acetate, propionate, and butyrate (the three saccharolytic SCFAs, short for short-chain fatty acids) are made when gut microbes break down fiber and resistant starch in the colon. They typically appear in roughly a 60:20:20 ratio of acetate to propionate to butyrate, though the exact balance depends on which bacteria are dominant and what you eat.

Each acid plays a distinct role. Butyrate is the primary fuel for the cells lining your colon, providing up to about 70% of their energy and helping seal the gut barrier. Propionate is largely absorbed by the liver and used to make glucose. Acetate, the most abundant of the three, circulates in your blood and feeds processes like fat and cholesterol synthesis, and it nudges the gut hormones GLP-1 and PYY (peptide YY, a gut hormone that suppresses appetite), which influence appetite and blood sugar.

Because these acids are absorbed so efficiently, only about 5 to 10% of what your microbes produce ends up in stool. That makes a stool measurement an indirect signal of total production, but it remains the most accessible window into colonic fermentation.

Inflammatory Bowel Disease and Gut Barrier Health

If you have ulcerative colitis or Crohn's disease, your stool SCFAs tend to drop, especially during active flares. A systematic review and meta-analysis of inflammatory bowel disease patients found significant reductions in fecal short-chain fatty acids, with the deepest declines during active inflammation and in chronic disease.

The link makes sense biologically: butyrate is the main fuel for colon cells, and when butyrate-producing bacteria like Faecalibacterium prausnitzii decline, the gut lining loses its preferred energy source. The result is a more permeable, more inflamed barrier.

Colorectal Cancer Risk

Lower fecal SCFAs are repeatedly associated with higher colorectal cancer risk. A systematic review and meta-analysis pooling colorectal cancer studies reported lower fecal butyrate and acetate in people with the disease compared to healthy controls, with butyrate showing the most consistent reduction. Propionate differences were less consistent.

An additional meta-analysis specifically focused on colorectal cancer incidence and risk stratification found that lower concentrations of acetic, propionic, and butyric acid in stool were associated with higher cancer risk and incidence. SCFA testing is not a replacement for colonoscopy or stool DNA tests, but a depleted SCFA pattern adds context that standard screening misses.

Irritable Bowel Syndrome

If you have unexplained gut symptoms, your SCFA pattern can hint at whether your microbiome is contributing. A meta-analysis of fecal short-chain fatty acids in irritable bowel syndrome found that patients tended to have higher fecal propionate and a lower acetate proportion compared to healthy controls.

Low-FODMAP diets, often used for IBS, were shown in the same meta-analysis to lower fecal propionate, suggesting the test can also reflect how dietary changes are reshaping your fermentation patterns.

Metabolic and Cardiovascular Signals

The relationship between fecal SCFAs and metabolic health is not a simple "more is better." In a study of 441 community-dwelling adults, higher fecal SCFA concentrations were associated with gut microbiome dysbiosis, greater gut permeability, obesity, hypertension, and other cardiometabolic risk markers. The leading interpretation is that these higher fecal levels reflect reduced absorption rather than greater production, meaning more of the SCFAs your microbes make are being excreted instead of put to work.

A separate study of 253 people found that circulating SCFAs in blood, but not fecal SCFAs, tracked closely with insulin sensitivity, lipolysis, GLP-1 levels, and triglycerides after adjusting for age, sex, and BMI. This is a counterintuitive piece of the picture: the same molecules signal different things in different compartments of the body.

Why a High Number Can Be Bad and a Low Number Can Be Bad

This is not a "higher is better" or "lower is better" marker. It is a phenotype indicator. Low fecal SCFAs in someone with IBD or active gut symptoms usually reflect reduced microbial fermentation and barrier vulnerability. High fecal SCFAs in someone with metabolic disease often reflect a different problem: the SCFAs are being produced but not absorbed efficiently, possibly due to faster transit or barrier issues. Two opposite directions can both signal trouble depending on the context, which is why this test is most useful when interpreted alongside symptoms, microbiome composition, and other markers.

Tracking Your Trend

A single SCFA reading is rarely diagnostic. These molecules are highly sensitive to what you ate in the last 24 to 72 hours, your medications, your stool consistency, and recent illness. Day-to-day variation in healthy people largely reflects recent fiber intake and microbial activity rather than a stable trait.

Get a baseline, then retest in 3 to 6 months if you are making changes to your fiber intake, fermented food consumption, prebiotic or probiotic use, or diet structure. After that, annual testing is reasonable for tracking trends. Pay attention to whether the absolute amounts and the ratios are shifting in the direction you want, especially the proportion of butyrate, which is the most consistently health-associated of the three.

When Results Can Be Misleading

• Recent diet within 24 to 72 hours: a high-fiber meal, resistant starch, or vinegar-rich foods can substantially shift values. Try to maintain your typical diet in the days before collection.
• Antibiotic use: broad-spectrum antibiotics, especially those targeting Gram-positive bacteria, can deplete butyrate-producing bacteria for weeks, lowering SCFAs without indicating chronic disease.
• Acute gastrointestinal illness: diarrhea, infection, or recent gut surgery can dramatically change transit time and SCFA absorption, distorting results.
• Sample handling: SCFAs are volatile. Delays between collection and analysis, or improper freezing, can lower measured values regardless of what your microbes actually produced.

What to Do With Abnormal Results

If your SCFAs are low and you have gut symptoms, consider pairing this test with calprotectin, a stool inflammation marker, and a comprehensive microbiome panel to see whether butyrate-producing taxa like Faecalibacterium prausnitzii or Roseburia are missing. If your fecal SCFAs are high but you have metabolic issues like obesity or hypertension, the more useful follow-up is metabolic testing such as fasting insulin, hs-CRP, and a lipid panel, since the high fecal number may reflect poor absorption rather than abundant healthy fermentation.

If you have persistent gut symptoms, blood in your stool, or a family history of colorectal cancer, do not let an SCFA result reassure or alarm you in isolation. A gastroenterologist should still guide colonoscopy timing and any structural workup. SCFAs add context, not certainty.